Rheumatology Advance Access published online on November 4, 2008
Rheumatology, doi:10.1093/rheumatology/ken404
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies: reply
1Department of Neurology and 2Department of Internal Medicine, Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan
Correspondence to:
S. Suzuki, Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: shigeaki@sc.itc.keio.ac.jp
| The first 10% of the full text of this article appears below. |
SIR, We appreciate Dr Liewluck's interest [1] in our work [2] and thank him for raising an important issue in the diagnosis of PM. As suggested, some types of myopathies including